What We Do
Screening is easy.
01
160+ Lab Tests
A single blood draw covers advanced lipids, hormones, cancer markers, metabolic panels, and longevity biomarkers, processed by certified labs.
02
Whole-Body Imaging
Radiation-free MRI scans every organ system simultaneously, detecting anomalies, aneurysms, and early tumors invisible to any blood test.
03
Results Explained
Every finding reviewed by a physician. You receive a prioritized action plan with clear next steps tailored to your age and risk profile.
04
Continuous Monitoring
Wearable biosensors worn at home track real-time cardiac rhythms and glucose response over weeks, revealing what a clinic visit never could.
Our Programs
Screenings curated
for your decade.
Select your age group to explore the full panel of diagnostics included in your personalized Klinos program.
The Foundation Panel
for your 40s.
for your 40s.
Your 40s are the most strategic decade to establish a health baseline. Many of the most treatable conditions cardiovascular disease, early cancers, metabolic dysfunction show their first silent signals now. This panel captures what standard medicine misses.
Functional Blood Panel
A deep-dive blood analysis beyond standard labs including advanced lipids, hormones, inflammatory markers, nutrients, and metabolic indicators.
Why it matters:
Standard cholesterol tests miss up to 50% of heart-attack risk. Functional panels reveal the full picture.
Standard cholesterol tests miss up to 50% of heart-attack risk. Functional panels reveal the full picture.
Whole Body MRI
A radiation-free full-body scan detecting soft tissue abnormalities, organ irregularities, aneurysms, and early tumors across all major organ systems.
Why it matters:
Over 25% of scans reveal clinically significant findings invisible to any standard exam.
Over 25% of scans reveal clinically significant findings invisible to any standard exam.
Coronary Calcium Score CT
A low-dose CT scan measuring calcium deposits in coronary arteries the gold standard for predicting cardiac events years before they occur.
Why it matters:
A zero score means near-zero 10-year cardiac risk. A high score triggers life-saving intervention.
A zero score means near-zero 10-year cardiac risk. A high score triggers life-saving intervention.
Germline Genetic Multi-Cancer Panel
Analyzes inherited gene variants (BRCA1/2, Lynch syndrome, and dozens more) indicating hereditary risk for breast, colon, ovarian, prostate, and other cancers.
Why it matters:
Hereditary cancers account for 5–10% of all cases and are preventable when caught early through genetics.
Hereditary cancers account for 5–10% of all cases and are preventable when caught early through genetics.
Continuous Glucose Monitor
A wearable biosensor worn for 3 months tracking real-time blood sugar responses to food, stress, sleep, and exercise revealing metabolic patterns a single fasting glucose never could.
Why it matters:
Pre-diabetes is largely invisible on standard labs. CGM detects insulin resistance years earlier.
Pre-diabetes is largely invisible on standard labs. CGM detects insulin resistance years earlier.
Ambulatory EKG
Extended cardiac rhythm monitoring worn over 1–2 weeks to capture intermittent arrhythmias, atrial fibrillation, and silent cardiac events that a 12-second clinic EKG routinely misses.
Why it matters:
A-fib is a leading cause of stroke yet 25% of cases are only detected by extended monitoring.
A-fib is a leading cause of stroke yet 25% of cases are only detected by extended monitoring.
Body Composition Analysis
Precise measurement of muscle mass, visceral fat, bone density, and lean tissue far beyond BMI, which tells you almost nothing about metabolic health.
Why it matters:
Visceral fat directly drives cardiovascular and metabolic disease. BMI alone misclassifies millions of people.
Visceral fat directly drives cardiovascular and metabolic disease. BMI alone misclassifies millions of people.
VO2 Max Testing
A medically graded cardiorespiratory fitness assessment measuring maximal oxygen uptake one of the most powerful predictors of longevity and all-cause mortality.
Why it matters:
Low VO2 Max carries a higher mortality risk than smoking, diabetes, or hypertension.
Low VO2 Max carries a higher mortality risk than smoking, diabetes, or hypertension.
The Clarity Panel
for your 50s.
for your 50s.
In your 50s, cumulative risk compounds. Cancer incidence rises sharply, cardiovascular calcification accelerates, and genetic risk translates into real-world probability. This panel adds two powerful tools: early cancer detection and Alzheimer's risk assessment.
Functional Blood Panel
Deep-dive blood analysis beyond standard labs including advanced lipids, hormones, inflammatory markers, nutrients, and metabolic indicators.
Why it matters:
Hormonal shifts in your 50s dramatically alter cardiovascular and metabolic risk profiles.
Hormonal shifts in your 50s dramatically alter cardiovascular and metabolic risk profiles.
Whole Body MRI
Radiation-free full-body scan detecting organ abnormalities, aneurysms, and early tumors across all major systems.
Why it matters:
Lesion detection rates increase significantly in this decade catching what can still be treated.
Lesion detection rates increase significantly in this decade catching what can still be treated.
Coronary Calcium Score CT
Measures coronary artery calcium deposits the gold standard for predicting cardiac events years before symptoms emerge.
Why it matters:
Coronary calcium progresses significantly through the 50s; catching acceleration changes treatment pathways.
Coronary calcium progresses significantly through the 50s; catching acceleration changes treatment pathways.
Germline Genetic Multi-Cancer Panel
Inherited gene variant analysis across BRCA1/2, Lynch syndrome, and dozens of hereditary cancer pathways.
Why it matters:
Genetic risk doesn't expire. Knowing it at 50 enables targeted surveillance and prevention strategies.
Genetic risk doesn't expire. Knowing it at 50 enables targeted surveillance and prevention strategies.
Continuous Glucose Monitor
3 months of real-time blood sugar tracking to reveal metabolic patterns invisible to standard fasting glucose tests.
Why it matters:
Type 2 diabetes risk peaks in the 50s; CGM catches insulin resistance years earlier than standard labs.
Type 2 diabetes risk peaks in the 50s; CGM catches insulin resistance years earlier than standard labs.
Ambulatory EKG
Extended cardiac rhythm monitoring for arrhythmia, atrial fibrillation, and silent cardiac events.
Why it matters:
A-fib prevalence doubles each decade after 50.
A-fib prevalence doubles each decade after 50.
Body Composition Analysis
Muscle mass, visceral fat, and bone density analysis tracking sarcopenia onset and metabolic change.
Why it matters:
Sarcopenia age-related muscle loss begins in the 50s and is entirely reversible when caught early.
Sarcopenia age-related muscle loss begins in the 50s and is entirely reversible when caught early.
VO2 Max Testing
Cardiorespiratory fitness assessment tracking functional health and guiding exercise prescription at this pivotal decade.
Why it matters:
VO2 Max decline accelerates in the 50s intervention now provides the greatest longevity return.
VO2 Max decline accelerates in the 50s intervention now provides the greatest longevity return.
Early Cancer Detection
Multi-cancer early detection blood test screening for 50+ cancer types using circulating tumor DNA added at this stage.
Why it matters:
Cancer incidence rises sharply in the 50s; liquid biopsy catches what imaging and standard labs never could.
Cancer incidence rises sharply in the 50s; liquid biopsy catches what imaging and standard labs never could.
APOE Genotype Testing
Alzheimer's genetic risk profiling determining eligibility for emerging anti-amyloid therapies.
Why it matters:
APOE status now determines eligibility for the newest Alzheimer's prevention treatments.
APOE status now determines eligibility for the newest Alzheimer's prevention treatments.
The Longevity Panel
for your 60s.
for your 60s.
In your 60s, the focus shifts to longevity optimisation and cellular aging. This panel adds biological age measurement allowing you to see whether your interventions are actually working at the cellular level.
Functional Blood Panel
Full-spectrum blood analysis tracking hormones, inflammation, metabolic function, and organ health with age-adjusted reference ranges.
Why it matters:
Cardiovascular and inflammatory markers take on new significance in this decade of compounding risk.
Cardiovascular and inflammatory markers take on new significance in this decade of compounding risk.
Whole Body MRI
Annual full-body scan providing comprehensive organ surveillance at the life stage of highest imaging yield.
Why it matters:
Detection rates for clinically actionable findings peak in this decade.
Detection rates for clinically actionable findings peak in this decade.
Coronary Calcium Score CT
Annual cardiac calcium monitoring to track progression and guide pharmacological intervention thresholds.
Why it matters:
Rate of calcium progression is as predictive as absolute score and only serial monitoring reveals it.
Rate of calcium progression is as predictive as absolute score and only serial monitoring reveals it.
Germline Genetic Multi-Cancer Panel
Comprehensive hereditary cancer variant analysis informing surveillance and screening frequency at this high-risk stage.
Why it matters:
Genetic results in your 60s guide decisions about prophylactic interventions that were not available a decade ago.
Genetic results in your 60s guide decisions about prophylactic interventions that were not available a decade ago.
Continuous Glucose Monitor
3-month real-time glucose tracking revealing metabolic flexibility and insulin response patterns.
Why it matters:
Metabolic syndrome drives dementia, cardiovascular disease, and cancer CGM is the earliest warning system.
Metabolic syndrome drives dementia, cardiovascular disease, and cancer CGM is the earliest warning system.
Ambulatory EKG
Extended arrhythmia monitoring capturing silent events that raise stroke risk by 500%.
Why it matters:
A-fib affects 10% of people over 65 and most cases are asymptomatic until stroke.
A-fib affects 10% of people over 65 and most cases are asymptomatic until stroke.
Body Composition Analysis
Comprehensive body composition assessment tracking muscle preservation, bone density, and metabolic mass.
Why it matters:
Frailty prevention starts with measurement. Intervening in the 60s has the greatest impact on independence.
Frailty prevention starts with measurement. Intervening in the 60s has the greatest impact on independence.
VO2 Max Testing
Cardiorespiratory fitness assessment that tracks functional health trajectory and guides exercise prescription.
Why it matters:
Maintaining VO2 Max above the 50th percentile for age is one of the most powerful longevity interventions.
Maintaining VO2 Max above the 50th percentile for age is one of the most powerful longevity interventions.
Early Cancer Detection
Multi-cancer liquid biopsy screening for 50+ cancer types using circulating tumor DNA analysis.
Why it matters:
Annual liquid biopsy at this stage provides the best early detection coverage of any single test available.
Annual liquid biopsy at this stage provides the best early detection coverage of any single test available.
APOE Genotype Testing
Alzheimer's risk profiling through APOE allele identification for treatment planning and emerging therapy eligibility.
Why it matters:
APOE status now determines eligibility for emerging anti-amyloid pharmacotherapy for Alzheimer's prevention.
APOE status now determines eligibility for emerging anti-amyloid pharmacotherapy for Alzheimer's prevention.
Plasma Phospho-Tau 217
Highly accurate blood biomarker detecting preclinical Alzheimer's tau pathology years before symptoms manifest.
Why it matters:
pTau-217 is now used to guide anti-amyloid therapy eligibility. Critical information at this stage of life.
pTau-217 is now used to guide anti-amyloid therapy eligibility. Critical information at this stage of life.
Epigenetic Clock Testing
DNA methylation-based biological age calculation tracking whether your longevity interventions are actually slowing your cellular clock.
Why it matters:
Allows objective measurement of whether lifestyle and medical interventions are working at the cellular level.
Allows objective measurement of whether lifestyle and medical interventions are working at the cellular level.
The Vitality Panel
for your 70s–120s.
for your 70s–120s.
In your 70s and beyond, the goal is preserving function, independence, and quality of life. This panel adds pharmacogenomic analysis ensuring every medication you take is metabolised safely by your unique biology.
Functional Blood Panel
Comprehensive blood analysis with age-optimised reference ranges tracking all key organ systems, hormones, and longevity biomarkers.
Why it matters:
Annual functional panels at this stage provide the earliest warning on treatable decline.
Annual functional panels at this stage provide the earliest warning on treatable decline.
Whole Body MRI
Comprehensive organ surveillance at the decade of highest imaging yield and most consequential early detection.
Why it matters:
A single finding on MRI at this stage can redirect a decade of health trajectory.
A single finding on MRI at this stage can redirect a decade of health trajectory.
Coronary Calcium Score CT
Cardiac calcium monitoring guiding statin and anti-inflammatory therapy decisions at peak cardiovascular risk.
Why it matters:
Cardiovascular disease is the leading cause of death after 70; this test directly informs life-saving intervention.
Cardiovascular disease is the leading cause of death after 70; this test directly informs life-saving intervention.
Germline Genetic Multi-Cancer Panel
Genetic cancer risk analysis guiding surveillance intensity and informing family risk counselling.
Why it matters:
Results influence both your own care and your children's and grandchildren's screening strategies.
Results influence both your own care and your children's and grandchildren's screening strategies.
Continuous Glucose Monitor
3-month glucose tracking that guards against hypoglycemia risk and optimises metabolic stability.
Why it matters:
Glucose instability in later life is strongly linked to cognitive decline continuous monitoring provides the earliest signal.
Glucose instability in later life is strongly linked to cognitive decline continuous monitoring provides the earliest signal.
Ambulatory EKG
Extended cardiac monitoring at the peak decade for atrial fibrillation, heart block, and silent arrhythmia.
Why it matters:
A-fib causes 1 in 4 strokes after 80. Detection and anticoagulation can prevent the majority.
A-fib causes 1 in 4 strokes after 80. Detection and anticoagulation can prevent the majority.
Body Composition Analysis
Muscle, bone, and fat analysis guiding targeted resistance training and nutritional intervention to prevent frailty.
Why it matters:
Sarcopenia and osteopenia are the leading modifiable causes of falls, fractures, and loss of independence.
Sarcopenia and osteopenia are the leading modifiable causes of falls, fractures, and loss of independence.
VO2 Max Testing
Fitness assessment tracking cardiorespiratory reserve and functional independence capacity.
Why it matters:
VO2 Max below the 25th percentile for age predicts inability to perform daily activities independently within 10 years.
VO2 Max below the 25th percentile for age predicts inability to perform daily activities independently within 10 years.
Early Cancer Detection
Multi-cancer liquid biopsy screening for 50+ cancer types using circulating tumor DNA analysis.
Why it matters:
Annual liquid biopsy at this stage provides the best early detection coverage of any single test available.
Annual liquid biopsy at this stage provides the best early detection coverage of any single test available.
APOE Genotype Testing
Alzheimer's risk profiling for treatment planning and emerging therapy eligibility.
Why it matters:
APOE status now determines eligibility for emerging anti-amyloid pharmacotherapy for Alzheimer's prevention.
APOE status now determines eligibility for emerging anti-amyloid pharmacotherapy for Alzheimer's prevention.
Plasma Phospho-Tau 217
Blood biomarker detecting preclinical Alzheimer's tau pathology years before symptoms manifest.
Why it matters:
pTau-217 is now used to guide anti-amyloid therapy eligibility. Critical information at this stage of life.
pTau-217 is now used to guide anti-amyloid therapy eligibility. Critical information at this stage of life.
Epigenetic Clock Testing
DNA methylation biological age calculation tracking whether longevity interventions are slowing your cellular clock.
Why it matters:
Allows objective measurement of whether lifestyle and medical interventions are working at the cellular level.
Allows objective measurement of whether lifestyle and medical interventions are working at the cellular level.
Added at 70s+
Pharmacogenomic Panel
Analyzes your genetic variants to predict how your body metabolizes over 100 commonly prescribed medications preventing dangerous interactions and poor drug responses before they occur.
Why it matters:
90% of people carry at least one variant affecting drug metabolism. Polypharmacy at 70+ makes this life-critical information.
90% of people carry at least one variant affecting drug metabolism. Polypharmacy at 70+ makes this life-critical information.
At a Glance
What's included
at each stage.
As you move through life's decades, tests are layered in. Every prior test carries forward.
Test
Functional Blood Panel
Whole Body MRI
Coronary Calcium CT
Genetic Cancer Panel
Continuous Glucose Monitor
Ambulatory EKG
Body Composition
VO2 Max
Early Cancer Detection
APOE Genotype
Phospho-Tau 217
Telomere Length
Epigenetic Clock
Pharmacogenomics
40s
Foundation
50s
Clarity
60s
Longevity
70s+
Vitality
Included
Added at this stage
Not included
Why Klinos
Medicine designed
around what matters.
10×earlier
Beyond the Annual Physical
Standard checkups diagnose illness. We screen for what could go wrong, years before symptoms arrive.
95%not covered
Not Covered by Design
Insurance funds reactive care. Our tests are elective precisely because they look forward, not at symptoms you already have.
4age panels
Curated for Your Decade
Risk accumulates differently at 42 versus 68. Each panel adds the right tests at exactly the right life stage.
100%physician reviewed
Actionable, Not Alarmist
Every result comes with physician interpretation and a prioritized action plan, not a raw data dump.
13+tests per panel
The Science of Longevity
Epigenetic clocks and telomere testing measure how your body is actually aging at the cellular level.
0waiting rooms
Private and Unhurried
No rushed appointments. Klinos coordinates everything with a concierge touch, from scheduling to results.